Literature DB >> 6547883

Amsacrine administration: a precautionary note.

C Engelking, P Sullivan, G Agoliati, Z A Arlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6547883     DOI： 10.1007/bf00257136

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  2 in total

1.  Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.

Authors:  Z A Arlin; R B Sklaroff; T S Gee; S J Kempin; J Howard; B D Clarkson; C W Young
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

2.  4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia.

Authors:  S S Legha; M J Keating; A R Zander; K B McCredie; G P Bodey; E J Freireich
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.